MRK - Merck & Co., Inc.

NYSE - NYSE Delayed Price. Currency in USD

Merck & Co., Inc.

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States

IndustryDrug Manufacturers - Major
Full Time Employees69,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Kenneth C. FrazierChairman, CEO & Pres4.35M17.56M1955
Mr. Robert M. DavisCFO & Exec. VP of Global Services3.45MN/A1967
Mr. Michael J. HolstonExec. VP & Gen. Counsel1.65M988.03k1962
Dr. Roger M. PerlmutterExec. VP & Pres of Merck Research Laboratories2.52MN/A1952
Mr. Adam H. SchechterExec. VP & Pres of Global Human Health2.23M1.81M1965
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Merck & Co., Inc. provides healthcare solutions worldwide. It operates in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company offers therapeutic and preventive agents to treat cardiovascular diseases, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases. It also provides neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors, and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. The company also provides companion animal products, such as ointments; diabetes mellitus treatment for dogs and cats; anthelmintic products; fluralaner products to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It has collaborations with Pfizer Inc., AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., and IO Biotech. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Corporate Governance

Merck & Co., Inc.’s ISS Governance QualityScore as of March 1, 2018 is 1. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 2; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.